MedPath

General drug use-results survey of UPASITA IV Injection Syringe for Dialysis

Not Applicable
Recruiting
Conditions
Secondary hyperparathyroidism under hemodialysis
Registration Number
JPRN-jRCT2041210113
Lead Sponsor
Dept. Pharmacovigilance
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
770
Inclusion Criteria

Patients with secondary hyperparathyroidism under hemodialysis who are using this drug for the first time

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath